Von Hippel-Lindau (VHL) 
Introduction

Von Hippel-Lindau (VHL) syndrome is a hereditary autosomal dominant syndrome characterized by the development of highly angiogenic tumors in the specific regions such as the retina, cerebellum, spinal cord, kidneys, adrenals, and epididymis (1). Several hundred germline mutations in the VHL gene have been reported (2) since the gene was identified by positional cloning in 1993 (3). VHL syndrome is classified into 2 categories, namely, type 1 and type 2 that have a low and high risk of pheochromocytoma (PHE), respectively. Type 2 VHL syndrome is further subclassified into a low (type 2A) and high (type 2B) risk of renal cell carcinoma (RCC) or cerebellar hemangioblastoma (HAB), and familial PHE without RCC or HAB is designated as type 2C (4). The VHL-encoded protein, pVHL, consists of 213 amino acids and possesses 2 functional subdomains, α and β (5). The α helical domain extends from codon 158 to 189 and binds elongin C, which in turn binds elongin B, Cullin2
, and Rbx1 to form an ubiquitin E3 ligase complex (6) . On the other hand, the β sheet corresponds to codon 63 to 157 and binds directly to hypoxia inducible factor (HIF) α subunits, thereby controlling the stability of HIF and tumor angiogenesis (6) In animal models, homozygous disruption of the VHL gene in mice results in embryonic lethality due to the lack of placental vasculogenesis (7) (8) (9) (10) . On the other hand, mice heterozygous for a VHL null mutation survive and are sus-F i g u r e 1 . a : T h e p l a i n ( u p p e r p a n e l ) a n d e n h a n c e d ( l o we r p a n e l ) CT f i n d i n g s o f p a t i e n t 1 . T h e a rr o ws d e n o t e b i l a t e r a l a d r e n a l t u mo r s . b : T h e I -MI B G s c i n t i g r a p h y o f p a t i e n t 1 . Al t h o u g h b i l a te r a l a d r e n a l g l a n d s we r e e n l a r g e d i n CT s c a n n i n g , I -MI B G wa s u p t a k e n o n l y i n t h e r i g h t a d r en a l g l a n d . Up p e r p a n e l s h o ws a n a n t e r i o r v i e w a n d l o we r p a n e l s h o ws a p o s t e r i o r v i e w. R: r i g h t ; L : l e f t .
ceptible to the development of spontaneous vascular tumors in the liver (8) (9) (10) as well as in other organs (9, 10) 
Subjects and Methods
Case report
A 65-year-old Japanese man (patient 1) 
. T h e a b d o mi n a l CT f i n d i n g s o f p a t i e n t 1 d e mo n s t r a t i n g mu l t i p l e h e p a t i c h e ma n g i o ma s .
a : n o n -e n h a n c e d CT ; b : e a r l y p h a s e a f t e r e n h a n c e me n t ; c : l a t e p h a s e a f t e r e n h a n c e me n t . R: r i g h t ; L : l e f t .
F i g u r e 3 . Di r e c t s e q u e n c e a n a l y s i s o f e x o n 2 o f t h e V HL g e n e i n p a t i e n t 1 . Co mp a r e d wi t h a n o r ma l s u b j e c t , t h e p at i e n t wa s h e t e r o z y g o u s f o r a C t o T t r a n s v e r s
i o n a t t h e f i r s t n u c l e o t i d e o f c o d o n 1 5 4 . T h i s mu t a t i o n wa s p r e d i c t e d t o r es u l t i n t h e s u b s t i t u t i o n o f p r o l i n e f o r s e r i n e a t c o d o n 1 5 4 . T h e a r r o w i n d i c a t e s t h e mu t a t i o n s i t e .
family.
Genetic analysis
Informed consent for analysis of the VHL gene was obtained from all 5 family members, and the study was approved by the ethical committee of the Kobe University Graduate School of Medicine (approval number: 274).
Genomic DNA was isolated from the peripheral blood leukocytes of the members and normal controls as described previously (11) . Each of the 3 exons of the VHL gene was individually amplified by polymerase chain reaction (PCR) with primer pairs described previously (12 
Results
Genetic analysis
As shown in Fig. 3, sequencing 
Restriction enzyme analysis
The sequence of the wild-type VHL gene contains a recognition site for BstN1. The C to T transition at the first base of codon 154 found in patients 1 and 2 disrupts this
F i g u r e 4 . Re s t r i c t i o n e n z y me a n a l y s i s o f t h e P CR p r o d u c t s o b t a i n e d f r o m t h e f a mi l y me mb e r s . T h e a g e s ( y e a r s ) o f t h e me mb e r s a r e i n d i c a t e d i n t h e p e d i g r e e . A 2 4 1 -b p f r a g me n t i nc l u d i n g e x o n 2 , wa s a mp l i f i e d b y P CR. T h e wi l d -t y p e P CR p r o d u c t s c o n t a i n e d a B s t N1 s i t e a n d p r o d u c e d 2 f r a g me n t s o f l e n g t h 1 3 9 a n d 1 0 2 b p b y d i g e s t i o n wi t h B s t N1 , wh e r e a s t h e C t o T t r a n s i t i o n d i s r u p t e d t h i s B s t N1 s i t e a n d wa s u n c u t b y B s t N1 . P a t i e n t 1 a n d 2 s h o we d 3 b a n d s c o n s i s t i n g o f 2 4 1 -, 1 3 9 -b p , a n d 1 0 9 -b p f r a g me n t s , i n d i c a t i n g t h e i r h e t e r o z y g o s i t y f o r t h i s mu t a t i o n , wh e r e a s t h e o t h e r f a mi l y me mb e r s s h o we d 2
b a n d s c o n s i s t i n g o f 1 3 9 -a n d 1 0 9 -b p f r a g me n t s . Fig. 4 One of the biochemical characteristics of PHE with VHL syndrome is relatively low levels of epinephrine secretion compared to norepinephrine, whereas PHE with MEN type 2 shows a high secretion of both epinephrine and norepinephrine (13) . It has been reported that relatively low levels of epinephrine in VHL syndrome is caused by the reduced activity of phenylethanolamine N-methyltransferase, the enzyme that converts norepinephrine to epinephrine (13) . In this regard, our results showing normal levels of epinephrine and increased levels of norepinephrine are in agreement with the characteristics of VHL syndrome. Although patient 1 possessed bilateral adrenal tumors, only the right adrenal tumor showed marked uptake of radioactivity in MIBG scintigraphy (Fig. 1) (2, (14) (15) (16) . In the patients with the P154S mutation of the VHL gene in our study, HAB was not observed and hepatic lesions showed a CT appearance typical of HH. McGrath et al (15) (2, 17) . Codon 154 is located at the boundary of the portion of the VHL gene that encodes α and β domains of pVHL. Therefore, it is possible that the mutation at codon 154 affects the function of both α and β domains of pVHL. In our study, 2 family members with the P154S mutation in the VHL gene developed PHE, whereas other members without a mutation did not (Fig. 4) 
recognition site. As shown in
